Showing 1871-1880 of 8824 results for "".
Science of Skincare Summit 2024: Social Media as Education Tool
https://practicaldermatology.com/conferences/science-skincare-summit-2024/science-of-skincare-summit-2024-social-media-as-education-tool/29448/Jennifer Liu, MD, a dermatologist and social media influencer (dermfluencer) talks with Practical Dermatology about using social media at a tool to educate various audiences with correct information about both products and conditions such as atopic dermatitis and psoriasis. This video was recorded aDermWire TV Extra: Dr. Bunick on BPO Study
https://practicaldermatology.com/series/dermwire-tv/dermwire-tv-extra-dr-bunick-bpo-study/29165/Practical Dermatology Editorial Board member Christopher Bunick, MD, FAAD, discusses the new Journal of Investigative Dermatology article he co-authored, "Evaluation of Benzene Presence and Formulation in Benzoyl Peroxide Drug Products."A Broad View of the Current Literature
https://practicaldermatology.com/conferences/maui-derm-2024/a-broad-view-of-the-current-literature/20263/Resident Of Distinction Award-winner Jason Klein, MD, PhD, a dermatology resident at the UT Southwestern Medical Center, talks about some of the latest developments in dermatology literature highlighted in review presentations at Maui Derm 2024, including an elegant synopsis of current options for tWhat are Dermatologists’ Obstacles to Buy and Bill?
https://practicaldermatology.com/conferences/maui-derm-2024/what-are-dermatologists-obstacles-to-buy-and-bill/20241/Challenges with fee schedules have prompted many dermatologists to consider the buy and bill model. In a conversation between Practical Dermatology’s Chief Medical Editor Neal Bhatia, MD and Mark Kaufmann, MD, associate clinical professor at Mount Sinai, the doctors discuss some of the opportunitiesTo Sell or Not to Sell to Private Equity?
https://practicaldermatology.com/conferences/scale-2023/to-sell-or-not-to-sell-to-private-equity/20195/Joel L. Cohen, MD, and George Hruza MD, discuss the pros and cons of selling to private equity. Pros include back-office support and better pricing on technology and supplies, while cons can include giving up autonomy.Weighing the Safety of Sunscreens
https://practicaldermatology.com/topics/skin-cancer-photoprotection/the-safety-of-sunscreens/20172/Adam Friedman, MD, provides compelling reasons to question the recent studies on sunscreen safety.What’s the Latest in Hair Management?
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/whats-the-latest-in-hair-management/20113/Chytra Anand, MD, Neil Sadick, MD, and Brooke Jackson, MD offer insights on the best approaches to managing hair from global clinical experience to strategies for understanding the needs of each individual patient, they share tips to improve clinical outcomes.Burnout; Qwo Campaign; Differin, Cetaphil Programs; DermTech Data: DermWireTV
https://practicaldermatology.com/topics/skin-cancer-photoprotection/burnout-qwo-campaign-differin-cetaphil-programs-dermtech-data-dermwiretv/20063/The Dr. Lorna Breen Health Care Provider Protection Act is headed to the president, as the latest Medscape Physician Burnout and Depression Report shows more than half of physicians experiencing burnout say it has a strong or severe impact on their life. Differin marks Retinoid Awareness Week. CetapDermWireTV Extra: Lubriderm Launches Skin Scholarship with the NHHF
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-extra-lubriderm-launches-skin-scholarship-with-the-nhhf/20060/Suzanne Goldstein, Senior Director of Marketing for Lubriderm, explains the Skin Scholarship sponsored by Lubriderm and created in partnership with the National Hispanic Health Foundation (NHHF). This scholarship program aims to increase representation and accessibility within the field.Exploring High-Dose Neurotoxin Injections
https://practicaldermatology.com/conferences/maui-derm-2022/exploring-high-dose-neurotoxin-injections/20055/Michael H. Gold, MD shares his thoughts on the potential benefits of high-dose neurotoxin injections for some patients. He discusses his experience and the kind of results he's been able to achieve.